ABSTRACT
Data have been accumulating on the risk of developing type 2 diabetes in patients receiving statins and on the potential adverse effects of these drugs on glycemic control in patients who already have type 2 diabetes. This article reviews data linking statin use and new-onset diabetes mellitus, the effects of statins on glycemic control in type 2 diabetes, the benefit-risk considerations of statin use and type 2 diabetes, and how these factors affect patient management.
- Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.
- Byron J. Hoogwerf, MD, FACP, FACE⇑
- Clinical Professor of Endocrinology/Medical Sciences Discipline, Central Michigan University College of Medicine, Mount Pleasant, MI; Emeritus, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH
- Address:
Byron J. Hoogwerf, MD, FACP, FACE, 8972 Huntington Pointe Drive, Sarasota, FL 34238; byronhoogwerf{at}gmail.com
ABSTRACT
Data have been accumulating on the risk of developing type 2 diabetes in patients receiving statins and on the potential adverse effects of these drugs on glycemic control in patients who already have type 2 diabetes. This article reviews data linking statin use and new-onset diabetes mellitus, the effects of statins on glycemic control in type 2 diabetes, the benefit-risk considerations of statin use and type 2 diabetes, and how these factors affect patient management.
- Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Jump to section
- Article
- ABSTRACT
- DO STATINS CAUSE DIABETES? A NEW LOOK AT OLD TRIALS
- DO ALL STATINS DO IT? DOES RISK VARY BY STATIN INTENSITY?
- RISK FACTORS FOR DIABETES IN NON–STATIN-TREATED PATIENTS
- RISK FACTORS FOR DIABETES IN STATIN-TREATED PATIENTS
- DO STATINS WORSEN GLYCEMIC CONTROL?
- HOW MIGHT STATINS INCREASE DIABETES RISK?
- BENEFIT OUTWEIGHS RISK
- GUIDELINES SUGGEST SHARED DECISION-MAKING
- DISCLOSURES
- REFERENCES
- Figures & Data
- Info & Metrics